Related Experiment Video
Updated: May 22, 2026
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
[Construction of A eukaryotic expression vector carrying the iNOS gene and its effect on A549 lung cancer cells]
Sujuan Ye1, Weihan Yang, Yu Wang
1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Background And Objective:
The iNOS gene is associated with NO-mediated antitumor effects. The aims of this study are to construct a eukaryotic expression plasmid that carries the iNOS gene and to detect the expression levels and antitumor effects of the iNOS gene on A549 lung cancer cells.
Methods:
A DNA fragment of the human iNOS coding sequence was amplified using reverse transcription polymerase chain reaction (RT-PCR). The DNA fragment was subsequently cloned into the multiple cloning sites of the eukaryotic expression vector pVAX. The recombinant plasmid was confirmed using restriction enzyme treatment, PCR, and sequencing and was then transfected into A549 lung cancer cells. The expression of the iNOS gene in the A549 lung cancer cells after transfection was verified by RT-PCR and Western blot analysis. The effects of iNOS on cell apoptosis, proliferation, and migration were identified by staining with Hoechst 3235, an MTT assay, and a scratch assay, respectively.
Results:
The results of the restriction enzyme digestion, PCR, and sequencing verified the successful construction of the eukaryotic expression plasmid pVAX-iNOS. The iNOS gene expression level was increased in the transfected A549 cells. Further experiments also showed increased cell apoptosis among the A549 lung cancer cells transfected with pVAX-iNOS. Meanwhile, the proliferation and migration of A549 cells were significantly inhibited by the enhanced iNOS gene expression.
Conclusion:
The recombinant eukaryotic expression vector pVAX-iNOS was successfully constructed and transfected into A549 cells. The enhanced iNOS gene expression significantly promoted cell apoptosis, whereas the proliferation and migration of A549 cells were inhibited. These findings contribute to the development of novel and effective gene therapies for lung cancer.
Insights
This study constructed a pVAX-iNOS plasmid and transfected it into lung cancer cells. Enhanced inducible nitric oxide synthase (iNOS) expression increased apoptosis and inhibited proliferation and migration.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Therapy
Context:
- Inducible nitric oxide synthase (iNOS) plays a role in NO-mediated antitumor effects.
- A549 lung cancer cells were used as a model system.
- Understanding iNOS gene expression is crucial for developing targeted cancer therapies.
Purpose:
- To construct a eukaryotic expression plasmid containing the iNOS gene (pVAX-iNOS).
- To transfect the pVAX-iNOS plasmid into A549 lung cancer cells.
- To evaluate the effects of enhanced iNOS gene expression on A549 cell apoptosis, proliferation, and migration.
Summary:
- The pVAX-iNOS recombinant plasmid was successfully constructed and confirmed via restriction enzyme digestion, PCR, and sequencing.
- Transfection of pVAX-iNOS into A549 cells led to increased iNOS gene expression.
- Enhanced iNOS expression significantly promoted apoptosis while inhibiting proliferation and migration in A549 cells.
Impact:
- Successful construction and transfection of pVAX-iNOS provide a tool for studying iNOS function in lung cancer.
- Demonstrates the potential of iNOS gene therapy to induce apoptosis and suppress tumor cell growth.
- Findings support the development of novel gene-based therapeutic strategies for lung cancer.
More Related Videos
09:12Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells
Published on: July 22, 2016
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020